137 related articles for article (PubMed ID: 20456406)
41. CD30-positive lymphoproliferative disorder in a red tattoo: regional lymphomatoid papulosis type C or pseudolymphoma?
Haus G; Utikal J; Geraud C; Goerdt S; Leverkus M
Br J Dermatol; 2014 Sep; 171(3):668-70. PubMed ID: 24689991
[No Abstract] [Full Text] [Related]
42. Atypical pyoderma gangresosum in inflammatory bowel disease. A severe diagnostic challenge.
Muñoz PS; Ugidos AF; Montiel PM; Yagüe TM; Garrido C; Herruzo JA
Rev Esp Enferm Dig; 2009 Aug; 101(8):585-7. PubMed ID: 19785502
[No Abstract] [Full Text] [Related]
43. [Cyclosporin A therapy in pyoderma gangraenosum].
Zumdick M; Schuppe HC; Goerz G
Hautarzt; 1993 May; 44(5):306-8. PubMed ID: 8320117
[TBL] [Abstract][Full Text] [Related]
44. Persistent agmination of lymphomatoid papulosis evolving to classical lesions of lymphomatoid papulosis.
Romero-Maté A; Martín-Fragueiro L; Miñano-Medrano R; Martinez-Morán C; Arias-Palomo D; Borbujo J
J Am Acad Dermatol; 2009 Dec; 61(6):1087-8. PubMed ID: 19925939
[No Abstract] [Full Text] [Related]
45. Pyoderma gangrenosum induced by episiotomy.
Alani A; Sadlier M; Ramsay B; Ahmad K
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26786531
[TBL] [Abstract][Full Text] [Related]
46. Sarcoidosis and pyoderma gangrenosum: an exceptional association. The role of trauma and immunosuppressive agents.
Herrero JE; Mascaró JM; Llambrich A; Herrero C
J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):97-9. PubMed ID: 15649201
[TBL] [Abstract][Full Text] [Related]
47. Complete and durable clinical response of malignant pyoderma to tacrolimus in combination with dapsone and prednisone.
Ciurea AM; Guitart J; Brieva J
Arch Dermatol; 2010 Jan; 146(1):102-3. PubMed ID: 20083712
[No Abstract] [Full Text] [Related]
48. Cogan's syndrome with pyoderma gangrenosum: management of two uncommon disorders with aggressive presentation in a patient.
Chua EP; Mallett RB; Dahiya S
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29925554
[TBL] [Abstract][Full Text] [Related]
49. Progressive annular verrucous erosive plaques on the face.
Boontaveeyuwat E; Rerknimitr P; Asawanonda P; NoppaKun N
Clin Exp Dermatol; 2019 Oct; 44(7):784-786. PubMed ID: 30447015
[No Abstract] [Full Text] [Related]
50. A case of pyoderma gangrenosum responding to high-dose intravenous immunoglobulin therapy.
Zhang XB; He YQ; Zhou H; Luo Q; Li CX
Chin Med J (Engl); 2006 Jul; 119(14):1230-2. PubMed ID: 16863619
[No Abstract] [Full Text] [Related]
51. [Oral involvement in lymphomatoid papulosis].
Serra-Guillén C; Requena C; Alfaro A; Hueso L; Sanmartín O; Llombart B; Nagore E; Botella-Estrada R; Martorell-Calatayud A; Guillén C
Actas Dermosifiliogr; 2007 May; 98(4):265-7. PubMed ID: 17506958
[TBL] [Abstract][Full Text] [Related]
52. Successful treatment of localized pyoderma gangrenosum with topical pimecrolimus.
Cecchi R; Pavesi M; Bartoli L; Brunetti L
J Cutan Med Surg; 2012; 16(5):295-7. PubMed ID: 22971301
[No Abstract] [Full Text] [Related]
53. Topical tacrolimus (FK 506) is effective in the treatment of pyoderma gangrenosum.
Richter-Hintz D; Schuppe HC; Homey B; Lehmann P; Ruzicka T
J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):304-5. PubMed ID: 10642695
[No Abstract] [Full Text] [Related]
54. Pyoderma gangrenosum of the breast treated with low-dose cyclosporin A.
Dolan OM; Burrows D; Walsh M
Clin Exp Dermatol; 1997 Mar; 22(2):92-5. PubMed ID: 9330074
[TBL] [Abstract][Full Text] [Related]
55. Pyoderma gangrenosum associated with Takayasu's arteritis.
Ujiie H; Sawamura D; Yokota K; Nishie W; Shichinohe R; Shimizu H
Clin Exp Dermatol; 2004 Jul; 29(4):357-9. PubMed ID: 15245528
[TBL] [Abstract][Full Text] [Related]
56. Accelerated healing of pyoderma gangrenosum in Behçet patient treated with cyclosporine and split thickness skin graft.
Kim DW; Lee BI; Park SH
Ann Plast Surg; 2008 Nov; 61(5):552-4. PubMed ID: 18948785
[TBL] [Abstract][Full Text] [Related]
57. Pyoderma gangrenosum in a renal transplantation patient having immunosuppressive treatment for 5 years.
Serdar ZA; Ata P; Titiz MI
Transpl Int; 2011 Nov; 24(11):e100-1. PubMed ID: 21902729
[No Abstract] [Full Text] [Related]
58. Combined therapy for pyoderma gangrenosum.
Rozin AP; Balbir-Gurman A; Gilead L; Slodownik D
Ann Rheum Dis; 2004 Jul; 63(7):888-9. PubMed ID: 15194593
[No Abstract] [Full Text] [Related]
59. Topical tacrolimus (FK506) in the treatment of recalcitrant parastomal pyoderma gangrenosum associated with Crohn's disease: report of two cases.
Khurrum Baig M; Marquez H; Nogueras JJ; Weiss EG; Wexner SD
Colorectal Dis; 2004 Jul; 6(4):250-3. PubMed ID: 15206967
[TBL] [Abstract][Full Text] [Related]
60. Review of 26 cases of classical pyoderma gangrenosum: clinical and therapeutic features.
Vidal D; Puig L; Gilaberte M; Alomar A
J Dermatolog Treat; 2004 Jun; 15(3):146-52. PubMed ID: 15204146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
